News
-
-
PRESS RELEASE
MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition
MIRA Pharmaceuticals announced new preclinical results for SKNY-1, an oral drug candidate targeting obesity and nicotine addiction, showing promise in reducing anxiety-like effects. The drug may offer a novel treatment approach for weight loss and craving management -
-
-
-
-
PRESS RELEASE
HORNBACH Holding AG & Co. KGaA: Annual General Meeting approves dividend of EUR 2.40 – solid performance in past financial year
HORNBACH Holding AG & Co. KGaA's Annual General Meeting approves dividend of EUR 2.40 for the 2024/25 financial year, with a distribution quota of 27.3%. CEO optimistic about future prospects -
-
PRESS RELEASE
Northern Superior Enters Into A Definitive Agreement For The Acquisition Of Strategic Properties In The Chibougamau Gold Camp
Northern Superior Resources Inc. has entered into an asset purchase agreement with TomaGold Corporation for the acquisition of properties. Transaction expected to close next week -
PRESS RELEASE
Orogen Royalties Re-Lists on the TSX Venture Exchange
Orogen Royalties Inc. announces its re-listing on TSX Venture Exchange under symbol 'OGN' resulting from completed plan of arrangement and strategic private placement with Triple Flag. Company focuses on organic royalty generation and strategic acquisition in the mining industry
